Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Montevialeon Aug 19, 2017 12:39pm
112 Views
Post# 26599629

Maybe someone can explain....

Maybe someone can explain....Aphria has investments in the USA and Canopy does not. 
 
Bruce Linton wants TMX to make a policy decision on how marijuana companies listed in Canada with interests in the USA, where cannabis remains federally illegal, are treated. 
 
Linton stated that his only interest in the issue is that it affects his company (Canopy) ability to raise funds from the US even though it doesn’t have US investments.    “They won’t invest in Canada in cannabis until the rules are clear and applied” he said. 
 
Linton is blaming Canadian companies doing business in US for his inability to attract US investment. 
 
However, Brian Kennedy, president of Tilray, a Canadian licensed medical cannabis producer, takes a different approach.  Tilray, is a wholly owned subsidiary of Privateer Holdings, a private equity firm headquartered in Seattle Washington.  Kennedy on BNN earlier this week stated that Tilray has been able to raise $140 million US from many investors around the world with many located in the US. 
 
Also to be fair to Tilray, they decided not to do business in the US (same position that Canopy has taken) because they view it as being too risky for their shareholders.  However, Kennedy has never used the illegality of cannabis at the federal level in the US as an excuse for not being able to raise money from US investors.   In fact, he is on record as saying that much of their capital was raised from US investors. 
 
“Why is it that Tilray is able to raise money from investors in the US and Canopy can't? 

Bullboard Posts